State Street Corporation »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by State Street Corporation

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by State Street Corporation from 13F filings

Historical chart of State Street Corporation investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by State Street Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by State Street Corporation

Quarter filed Position value Share count Share price at filing
2024-06-30 $16M 15M 1.11
2024-03-31 $15M 16M 0.98
2023-12-31 $14M 15M 0.93
2023-09-30 $21M 23M 0.94

More positions owned by State Street Corporation

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Exxon Mobil Corporation (XOM)
JPMorgan Chase & Co. (JPM)
Chevron Corporation (CVX)
UnitedHealth (UNH)
Tesla Motors (TSLA)

View all positions for State Street Corporation

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&G
Calamos Advisors
Wolverine Asset Management
MacKay Shields
Lazard Asset Management
Millennium Management
BlackRock
Camden Asset Management
Advent Capital Management
Polar Securities
Bank of America Corporation
Magnetar Financial
State Street Corporation
CNH Partners
Citadel Advisors

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1